Great questions! In RA, it's less about producing *more* B cells and more about B cells behaving badly. They create autoantibodies that mistakenly attack the synovium (the lining of your joints), and also release a damaging signaling protein called tumor necrosis factor alpha (TNF-α), which is a type of cytokine that drives Show Full Answer
Great questions! In RA, it's less about producing *more* B cells and more about B cells behaving badly. They create autoantibodies that mistakenly attack the synovium (the lining of your joints), and also release a damaging signaling protein called tumor necrosis factor alpha (TNF-α), which is a type of cytokine that drives inflammation and bone damage.
Here's what's happening in the joints:
- B cells produce autoantibodies like rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA)
- These autoantibodies trigger immune responses that inflame and damage the synovium
- TNF-α and other cytokines (like interleukins) are released, amplifying inflammation
- Over time, this leads to a thickened, destructive tissue called "pannus" that erodes cartilage and bone As for measuring these, doctors typically use:
- Blood tests – to detect RF and ACPA antibody levels, as well as inflammatory markers like CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate)
- Imaging – X-rays or MRI scans to assess joint and bone damage caused by ongoing inflammation
- Cytokine panels – specialized blood tests that can measure TNF-α and interleukin levels, though these are more commonly used in research settings
It's worth discussing with a rheumatologist which tests make the most sense for monitoring disease activity in your specific situation.
August 13
Join
Your Privacy Choices
